new drug
(subgroup of
drug)
→
HasProperty
→
effective
|
0.77 | |
new drug
(subgroup of
drug)
→
HasProperty
→
safe
|
0.76 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
approved by the fda
|
0.76 | |
new drug
(subgroup of
drug)
→
CapableOf
→
enter the market
|
0.76 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
approved
|
0.69 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
tested
|
0.67 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
brought to market
|
0.66 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
developed
|
0.64 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
created
|
0.59 | |
new drug
(subgroup of
drug)
→
CapableOf
→
enter clinical trials
|
0.57 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
tested in clinical trials
|
0.57 | |
new drug
(subgroup of
drug)
→
CapableOf
→
become available
|
0.57 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
sold
|
0.55 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
introduced
|
0.55 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
proven safe
|
0.54 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
described in section 505(a
|
0.54 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
tested on animal
|
0.54 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
prescribed
|
0.53 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
investigated
|
0.53 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
patented
|
0.52 | |
new drug
(subgroup of
drug)
→
CapableOf
→
receive fda approval
|
0.51 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
synthesized
|
0.51 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
released
|
0.47 | |
new drug
(subgroup of
drug)
→
HasProperty
→
expensive
|
0.47 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
protected by patent
|
0.46 | |
new drug
(subgroup of
drug)
→
CapableOf
→
prove effective
|
0.46 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
added
|
0.46 | |
new drug
(subgroup of
drug)
→
HasProperty
→
excellent
|
0.45 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
marketed
|
0.44 | |
new drug
(subgroup of
drug)
→
CapableOf
→
shown promise
|
0.43 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
launched
|
0.42 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
compared with placebo
|
0.42 | |
new drug
(subgroup of
drug)
→
CapableOf
→
treat cancer
|
0.40 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
approved in the u.s.
|
0.40 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
injected into the eye
|
0.40 | |
new drug
(subgroup of
drug)
→
IsA
→
invented the company
|
0.40 | |
new drug
(subgroup of
drug)
→
HasProperty
→
superior
|
0.39 | |
new drug
(subgroup of
drug)
→
CapableOf
→
save life
|
0.39 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
reviewed
|
0.39 | |
new drug
(subgroup of
drug)
→
CapableOf
→
show promise
|
0.38 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
reimbursed
|
0.38 | |
new drug
(subgroup of
drug)
→
CapableOf
→
treat disease
|
0.38 | |
new drug
(subgroup of
drug)
→
HasProperty
→
successful
|
0.38 | |
new drug
(subgroup of
drug)
→
IsA
→
antibody
|
0.37 | |
new drug
(subgroup of
drug)
→
HasProperty
→
more effective
|
0.37 | |
new drug
(subgroup of
drug)
→
HasProperty
→
beneficial
|
0.37 | |
new drug
(subgroup of
drug)
→
CapableOf
→
treat alzheimer
|
0.37 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
studied
|
0.36 | |
new drug
(subgroup of
drug)
→
CapableOf
→
cure hepatitis c
|
0.35 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
licensed for use
|
0.35 | |
new drug
(subgroup of
drug)
→
HasA
→
side effects
|
0.34 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
discovered
|
0.34 | |
new drug
(subgroup of
drug)
→
CapableOf
→
help people
|
0.34 | |
new drug
(subgroup of
drug)
→
HasA
→
the effect
|
0.34 | |
new drug
(subgroup of
drug)
→
IsA
→
on the horizon
|
0.34 | |
new drug
(subgroup of
drug)
→
IsA
→
improvement
|
0.34 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
started
|
0.34 | |
new drug
(subgroup of
drug)
→
HasProperty
→
dangerous
|
0.34 | |
new drug
(subgroup of
drug)
→
AtLocation
→
the pipeline
|
0.33 | |
new drug
(subgroup of
drug)
→
CapableOf
→
receive approval
|
0.32 | |
new drug
(subgroup of
drug)
→
CapableOf
→
await approval
|
0.32 | |
new drug
(subgroup of
drug)
→
CapableOf
→
reach patient
|
0.32 | |
new drug
(subgroup of
drug)
→
CapableOf
→
treat advanced cases of multiple sclerosis
|
0.32 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
tested on mouse
|
0.32 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
registered
|
0.31 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
tested against placebo
|
0.31 | |
new drug
(subgroup of
drug)
→
CapableOf
→
target enzyme
|
0.30 | |
new drug
(subgroup of
drug)
→
CapableOf
→
target protein
|
0.30 | |
new drug
(subgroup of
drug)
→
CapableOf
→
treat depression
|
0.30 | |
new drug
(subgroup of
drug)
→
CapableOf
→
offer hope
|
0.29 | |
new drug
(subgroup of
drug)
→
HasA
→
fewer side effects
|
0.29 | |
new drug
(subgroup of
drug)
→
CapableOf
→
be a godsend
|
0.28 | |
new drug
(subgroup of
drug)
→
CapableOf
→
take year
|
0.28 | |
new drug
(subgroup of
drug)
→
CapableOf
→
prevent heart attacks
|
0.28 | |
new drug
(subgroup of
drug)
→
HasProperty
→
less toxic
|
0.28 | |
new drug
(subgroup of
drug)
→
HasProperty
→
better than old ones
|
0.28 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
had to clear high bar
|
0.28 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
approved by health canada
|
0.28 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
studied in child
|
0.28 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
used in combination
|
0.28 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
approved in 2017
|
0.28 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
presented as breakthrough
|
0.28 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
added to the formulary
|
0.28 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
approved in 2015
|
0.28 | |
new drug
(subgroup of
drug)
→
CapableOf
→
cure the disease
|
0.27 | |
new drug
(subgroup of
drug)
→
CapableOf
→
treat hiv
|
0.25 | |
new drug
(subgroup of
drug)
→
HasProperty
→
safer
|
0.25 | |
new drug
(subgroup of
drug)
→
CapableOf
→
treat infectious diseases
|
0.25 | |
new drug
(subgroup of
drug)
→
CapableOf
→
treat opioid addiction
|
0.25 | |
new drug
(subgroup of
drug)
→
CapableOf
→
improve survival
|
0.25 | |
new drug
(subgroup of
drug)
→
CapableOf
→
target receptor
|
0.25 | |
new drug
(subgroup of
drug)
→
CapableOf
→
benefit child
|
0.25 | |
new drug
(subgroup of
drug)
→
CapableOf
→
extend life
|
0.25 | |
new drug
(subgroup of
drug)
→
CapableOf
→
reverse two major risk factors
|
0.25 | |
new drug
(subgroup of
drug)
→
CapableOf
→
target same diseases
|
0.25 | |
new drug
(subgroup of
drug)
→
CapableOf
→
become popular
|
0.25 | |
new drug
(subgroup of
drug)
→
CapableOf
→
improve treatment of the symptoms
|
0.25 | |
new drug
(subgroup of
drug)
→
CapableOf
→
carry out autopsy
|
0.25 | |
new drug
(subgroup of
drug)
→
CapableOf
→
address unmet medical needs
|
0.25 | |
new drug
(subgroup of
drug)
→
HasA
→
novel mechanisms of action
|
0.25 | |
new drug
(subgroup of
drug)
→
HasProperty
→
identical
|
0.25 | |
new drug
(subgroup of
drug)
→
IsA
→
monoclonal antibodies
|
0.25 | |
new drug
(subgroup of
drug)
→
IsA
→
pill
|
0.25 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
intended for use
|
0.25 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
tested on cell
|
0.25 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
developed by amgen
|
0.25 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
launched in canada
|
0.25 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
close to decade
|
0.25 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
required
|
0.25 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
approved under anda
|
0.25 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
tested in the united states
|
0.25 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
approved for public use
|
0.25 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
targeted
|
0.25 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
used in concert
|
0.25 | |
heroin → IsA → new drug | 0.25 | |
new drug
(subgroup of
drug)
→
CapableOf
→
hit street
|
0.23 | |
new drug
(subgroup of
drug)
→
HasProperty
→
ineffective
|
0.23 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
developed to treat tb
|
0.23 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
intended to treat serious conditions
|
0.23 | |
new drug
(subgroup of
drug)
→
CapableOf
→
interact with thyroidal axis
|
0.22 | |
new drug
(subgroup of
drug)
→
CapableOf
→
activate immune system
|
0.19 | |
new drug
(subgroup of
drug)
→
CapableOf
→
look good
|
0.19 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
tolerated
|
0.19 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
used at lower doses
|
0.19 | |
new drug
(subgroup of
drug)
→
CapableOf
→
work in different way
|
0.16 | |
new drug
(subgroup of
drug)
→
CapableOf
→
reduce blood glucose levels
|
0.16 | |
new drug
(subgroup of
drug)
→
CapableOf
→
improve cognition
|
0.16 | |
new drug
(subgroup of
drug)
→
CapableOf
→
treat lupus
|
0.16 | |
new drug
(subgroup of
drug)
→
CapableOf
→
last at least 30 days
|
0.16 | |
new drug
(subgroup of
drug)
→
HasProperty
→
unsafe
|
0.16 | |
new drug
(subgroup of
drug)
→
HasProperty
→
life-changing
|
0.16 | |
new drug
(subgroup of
drug)
→
CapableOf
→
treat tuberculosis
|
0.09 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
removed
|
0.09 | |
new drug
(subgroup of
drug)
→
ReceivesAction
→
approved for motor neurone disease
|
0.00 |